You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HES

Showing 1 - 25 of 337
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uptake of Childhood Live Attenuated Influenza Vaccine and

Completed
  • Influenza
    • London, United Kingdom
      CPRD
    Oct 4, 2023

    Arterial Bleeding in Solid Organs and Peripheral Arteries Trial (Embrace HES including Instylla™ Delivery Kit and Instylla™

    Recruiting
    • Arterial Bleeding in Solid Organs and Peripheral Arteries
    • Embrace HES including Instylla™ Delivery Kit and Instylla™ Microcatheter
    • Long Beach, California
    • +1 more
    Dec 16, 2022

    Hypereosinophilic Syndrome (HES) Trial (Nilotinib)

    No longer available
    • Hypereosinophilic Syndrome (HES)
    • (no location specified)
    Sep 14, 2021

    Adverse Effect Trial (Hydroxyethyl starch coload - 0 ml/kg, Hydroxyethyl starch coload - 5 ml/kg, Hydroxyethyl starch coload -

    Not yet recruiting
    • Adverse Effect
    • Hydroxyethyl starch coload - 0 ml/kg
    • +2 more
    • (no location specified)
    Jan 25, 2023

    Postoperative Complications Trial in Xi'an (Intravenous HES130/0.4 of 5ml/kg, intravenous Lactated Ringer's solution)

    Not yet recruiting
    • Postoperative Complications
    • Intravenous HES130/0.4 of 5ml/kg
    • intravenous Lactated Ringer's solution
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Feb 14, 2023

    Preventative Medicine Trial in Lausanne (Mental Health First Aid (educational training program))

    Completed
    • Preventative Medicine
    • Mental Health First Aid (educational training program)
    • Lausanne, Vaud, Switzerland
      La Source, School of Nursing Sciences, HES-SO University of Appl
    Sep 6, 2023

    Postoperative Kidney Injury Trial in Cleveland (human albumin 5%, HES 130/0.4 (Voluven))

    Completed
    • Postoperative Kidney Injury
    • human albumin 5%
    • HES 130/0.4 (Voluven)
    • Cleveland, Ohio
      Cleveland Clinic Foundation
    Apr 18, 2022

    Body Dissatisfaction Trial in Genève (Body Project (BP), Healthy Weight Program (HW))

    Completed
    • Body Dissatisfaction
    • Body Project (BP)
    • Healthy Weight Program (HW)
    • Genève, Carouge, Switzerland
      School of Health Sciences (HES-SO Geneva)
    Jul 13, 2022

    Pulmonary Edema Trial in Cairo (Thoracic fluid content estimation)

    Completed
    • Pulmonary Edema
    • Thoracic fluid content estimation
    • Cairo, Manial, Egypt
      Cairo University hospitals
    Mar 10, 2022

    Hypereosinophilic Syndrome Trial in Worldwide (Benralizumab, Placebo)

    Recruiting
    • Hypereosinophilic Syndrome
    • Benralizumab
    • Placebo
    • La Jolla, California
    • +45 more
    Feb 2, 2023

    Hypereosinophilic Syndrome Trial (Depemokimab, Placebo)

    Recruiting
    • Hypereosinophilic Syndrome
    • Atlanta, Georgia
    • +18 more
    Feb 1, 2023

    Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

    Active, not recruiting
    Has Results
    • Respiratory System Agents
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022

    Hypervascular Tumors Trial in Melbourne (Instylla HES, TAE or cTACE)

    Recruiting
    • Hypervascular Tumors
    • Instylla HES
    • TAE or cTACE
    • Melbourne, Victoria, Australia
      Alfred Health
    Feb 9, 2021

    Eosinophilia, Hypereosinophilic Syndrome Trial in Stanford (Gleevec)

    Terminated
    • Eosinophilia
    • Hypereosinophilic Syndrome
    • Stanford, California
      Stanford University School of Medicine
    May 5, 2021

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Psychological Distress Trial in Lausanne (Ensemble programme, SAU)

    Active, not recruiting
    • Psychological Distress
    • Ensemble programme
    • SAU
    • Lausanne, Vaud, Switzerland
      La Source, School of Nursing Sciences, HES-SO University of Appl
    Aug 16, 2021

    Mild Cognitive Impairment Trial in Lausanne, Geneva (Music practice, Psychomotor therapy)

    Enrolling by invitation
    • Mild Cognitive Impairment
    • Music practice
    • Psychomotor therapy
    • Lausanne, Vaud, Switzerland
    • +1 more
    Oct 30, 2021

    Hypovolaemia Due to Acute Blood Loss Trial in Worldwide (Volulyte 6%, Ionolyte)

    Active, not recruiting
    • Hypovolaemia Due to Acute Blood Loss
    • Sankt Veit, Austria
    • +60 more
    May 23, 2022

    Hypereosinophilic Syndrome Trial (Mepolizumab)

    No longer available
    • Hypereosinophilic Syndrome
    • (no location specified)
    Nov 23, 2020

    Programme Data Linkage With HES and ONS Datasets

    Unknown status
    • AAA
    • this field is not applicable
    • Leicester, United Kingdom
      University of Leicester
    Mar 8, 2020

    Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad Trial in Innsbruck (no intervention)

    Recruiting
    • Eosinophilic Asthma
    • +4 more
    • no intervention
    • Innsbruck, Austria
      University Clinic for Internal Medicine II
    Sep 2, 2020

    Endothelial Dysfunction Trial in Cleveland (Human albumin, Hydroxyethyl starch)

    Completed
    • Endothelial Dysfunction
    • Human albumin
    • Hydroxyethyl starch
    • Cleveland, Ohio
      Cleveland Clinic
    Jul 20, 2020

    Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

    Recruiting
    • Eosinophilic Myeloid Neoplasm
    • Hypereosinophilic Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    In Silico Trials of Surgical Interventions

    Active, not recruiting
    • Cardiovascular Diseases
      • Leicester, Leicestershire, United Kingdom
        Department of Cardiovascular Sciences, University of Leicester,
      May 9, 2023

      Hypereosinophilia, Hypereosinophilic Syndrome Trial in Worldwide (mepolizumab)

      Completed
      • Hypereosinophilia
      • Hypereosinophilic Syndrome
      • San Diego, California
      • +28 more
      May 1, 2020